Sterling Heights, MINCT07535034Now EnrollingIRB Ready

Gout Clinical Trial in Sterling Heights, MI

Access cutting-edge gout treatment through this clinical trial at a research site in Sterling Heights. Study-provided care at no cost to qualified participants.

Sponsored by Crystalys Therapeutics

Quick Self-Assessment

See if you qualify for this Sterling Heights location

Preparing your pre-screening questions…

Expert Care in Sterling Heights

Access gout specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related gout treatment provided free

Apply for This Sterling Heights Location

Check if you qualify for this gout clinical trial in Sterling Heights, MI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Sterling Heights

    Convenient for MI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Sterling Heights site if eligible
  4. 4Begin participation

About This Gout Study in Sterling Heights

The primary objective of this trial is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 in participants with gout who are XOI intolerant or have failed uricase treatment.

Sponsor: Crystalys Therapeutics

Who Can Participate

Inclusion Criteria

Between 18 and 75 years of age (inclusive) at the time of signing informed consent.
Diagnosis of gout based on 2015 American College of Rheumatology (ACR)-European Union League Against Rheumatism (EULAR) criteria for at least 1 year and has at least 1 of the following:
History (either by medical record or participant interview) of intolerance or a contraindication to either allopurinol or febuxostat.
Failed uricase treatment (eg, an sUA level \>6.0 mg/dL at least 2 weeks after last infusion; intolerant or contraindicated to uricase treatment).
sUA level \>6.0 and \<10.5 mg/dL at both Screening Visit 1 (Day -28 Visit) and Screening Visit 2 (Day -7 Visit).
Female participants of childbearing potential must have a negative serum pregnancy test at Screening Visit 1 (Day -28 Visit), a negative urine pregnancy test on Day 1, and must not be breastfeeding.
Fertile male participants and female participants of childbearing potential must be willing to completely abstain from heterosexual sex or agree to use acceptable contraception from the time of signing informed consent through 30 days after the last dose of trial drug.

Exclusion Criteria

History of or presence of kidney stones within 1 year prior to Screening.
History of or presence of malignancy in the last 5 years other than treated cutaneous basal or squamous cell carcinoma.
Known or suspected history of drug abuse, a positive drug test at Screening Visit 1, or a recent history of alcohol abuse.
Known history of or positive results for human immunodeficiency virus (HIV), Hepatitis B surface antigen (HBsAg), or Hepatitis C virus (HCV) during Screening.
Current or historical evidence of any clinically significant disease or condition that, in the opinion of the Investigator, may compromise participant safety or trial compliance or may confound interpretation of trial results.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Sterling Heights?

Yes, this clinical trial (NCT07535034) has an active research site in Sterling Heights, MI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Gout Treatment Options in Sterling Heights, MI

If you're searching for gout treatment options in Sterling Heights, MI, this clinical trial (NCT07535034) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Sterling Heights research site is actively enrolling participants for this clinical trial. You'll receive care from experienced gout specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all gout clinical trials near you to find additional studies recruiting in your area.

More Gout Trials in Sterling Heights, MI

See all gout clinical trials recruiting in Sterling Heights — not just this study.

Browse Gout Trials in Sterling Heights →

Browse More Trials by Condition

Gout TrialsAll Conditions →

Ready to Join in Sterling Heights?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Sterling Heights, MI